Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma

PURPOSE: Prediction of clinical outcomes in patients with primary central nervous system lymphoma (PCNSL) is important for optimization of treatment planning. Quantitative imaging biomarkers for PCNSL have not yet been established. This study evaluated the prognostic value of pretreatment dynamic co...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Neurooncol
Main Authors: Hatzoglou, Vaios, Oh, Jung Hun, Buck, Olivia, Lin, Xuling, Lee, Michelle, Shukla-Dave, Amita, Young, Robert J., Peck, Kyung K., Vachha, Behroze, Holodny, Andrei I., Grommes, Christian
格式: Artigo
語言:Inglês
出版: 2018
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6609090/
https://ncbi.nlm.nih.gov/pubmed/30073640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-018-2960-z
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍